Why the study?
To compare mortality in patients with HFrEF and permanent AF treated with AVJA plus CRT against a contemporary cohort of similar patients in sinus rhythm.
Does AVJA plus CRT improve all-cause mortality in patients with HFrEF, narrow QRS, and permanent AF compared to ICD alone in similar patients in sinus rhythm?
Does AVJA plus CRT improve all-cause mortality in patients with HFrEF, narrow QRS, and permanent AF compared to ICD alone in similar patients in sinus rhythm?
In patients with HFrEF, narrow QRS, and permanent AF, AVJA plus CRT results in similar long-term mortality compared to a matched cohort of patients in sinus rhythm receiving an ICD.
Comparable mortality with AVJA plus CRT versus sinus-rhythm ICD; leaves open randomized trials versus rate control in narrow-QRS permanent AF.
No takes yet. Share an insight, caveat, or question.
Palmisano et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: